Navigation Links
Facet Solutions Announces 2 Year Data from US Pilot Study
Date:4/23/2010

HOPKINTON, Mass., April 23 /PRNewswire/ -- Facet Solutions, Inc. today announced that it has finished compiling two year data from its lumbar stenosis pilot study in the US. At two years, patients in the ACADIA™ study experienced significant and sustained improvement in Oswestry Disability Index, VAS back pain and VAS leg pain.  There were no re-operations in any of the patients, and all patients met the definition of success for ODI improvement.

"Treating lumbar stenosis today represents a compromise for lumbar stenosis patients," commented Dr. James Youssef of SpineColorado in Durango, CO. "With existing procedures, we can maintain motion in the segment, but must leave in at least 50% of the facets which often contributed to the problem in the first place.  Alternatively, we can remove all of the pathology but must fuse the patient to re-stabilize.  By contrast, using the ACADIA™ procedure, we are able to fully decompress, removing all pain generators, and implant ACADIA™ to re-establish stability and motion for the patient."  

"These results represent a leap forward for treating lumbar stenosis," stated Facet Solutions' President & CEO, Geoff Pardo. "The results at one year were impressive, but the fact that they were sustained across the board at two years is particularly noteworthy."  Facet Solutions, Inc. has developed ACADIA™ to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The ACADIA™ procedure includes replacement of the degenerated posterior spinal joints with an anatomic implant that is designed to restore the natural motion, stability, and balance to the lumbar spine. Facet Solutions is actively enrolling its US Pivotal IDE trial at 16 centers across the United States.

Dr. James Youssef, SpineColorado in Durango, CO, will be presenting a worldwide clinical update at the upcoming Spine Arthroplasty Society meeting in New Orleans, LA on Friday, April 30th at 9:06am.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures and Spray Venture Partners. Facet Solutions is certified to ISO 13485. ACADIA™ is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
2. Facet Solutions Completes Facet Joint and Disc Replacement Study
3. Facet Solutions Establishes Corporate Headquarters and Expands Executive Team
4. US Facet Fixation Market to Increase by Over 60% Annually Through 2012
5. Healthcare Data Solutions Announces Latest Database, PrescriberPRO@Home.
6. Haydon Kerk Motion Solutions, Inc. Introduces the New 20mm Stepper Motor Linear Actuator
7. Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies
8. Healthcare Data Solutions Announces New AnalyticPRO division.
9. Community Health Solutions of America Engages Chronically Ill Members With MEDais Risk Navigator Suite
10. MedShape Solutions, Inc. Announces Commercialization of SBIR Funded Technology: Receives Purchasing Preference in Federally Funded Hospitals and Health Care Facilities
11. RESolutions Rapid Enrollment Solutions, LLC Announces Launch of Novel Patient Recruitment Web Site - Clinical Trial Spotlight™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... Philadelphia, PA (PRWEB) , ... October 10, 2017 ... ... University City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. ... accept the award for Excellence in Volunteer Experience from US2020. , US2020’s mission ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
Breaking Biology News(10 mins):